Kizoo leads financing round in Reservoir Neuroscience to restore health to the aging brain SAN FRANCISCO and BERLIN, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Reservoir Neuroscience announced today the completion of a $4M financing round to support the development of new therapies for age-related...

Kizoo invests in Rejuvenation Startup Mogling Bio BERLIN and ULM, Germany, Oct. 26, 2022 (GLOBE NEWSWIRE) -- Mogling Bio, a privately held biotech company, announces today that it has successfully completed its first seed investment round. Sole...

Kizoo Portfolio Company Elastrin Therapeutics Inc. closes $10M Funding Round GREENVILLE, S.C., April 07, 2022 (GLOBE NEWSWIRE) -- Elastrin Therapeutics Inc., a privately held biotechnology company leveraging a platform to develop therapeutics that render calcified tissue and...

Kizoo Portfolio Company Revel Pharmaceuticals Announces $8.4M Seed to Develop Repairing-Based Approaches to Reversing Aging SAN FRANCISCO, March 17, 2022 (GLOBE NEWSWIRE) -- Revel Pharmaceuticals, a longevity therapeutics company developing enzymes to repair damage from aging, announced today that it has raised $8.4M in...

Kizoo Portfolio Company Underdog Closes $10M Financing Round MOUNTAIN VIEW, Calif., Sept. 23, 2021 (GLOBE NEWSWIRE) -- Underdog Pharmaceuticals, a key investment of Michael Greve's rejuvenation biotech VC Kizoo, has closed a $10 million round of capital....